Sato Y, Tanda H, Kato S, Onishi S, Nakajima H, Nanbu A, Nitta T, Koroku M, Akagashi K, Hanzawa T
Department of Urology, Sapporo Sanjukai Hospital, Higashi-Sapporo, Shiroishi-ku, Sapporo, Japan.
Int J Impot Res. 2007 Jul-Aug;19(4):407-10. doi: 10.1038/sj.ijir.3901551. Epub 2007 Apr 26.
The goal was to clarify the rate of major depressive disorder (MDD) in self-referred patients who visited our late onset hypogonadism (LOH) clinic and the importance of screening of MDD in LOH clinic. Two hundred consecutive self-referred patients who visited our LOH clinic were evaluated. MDD was diagnosed using, the Mini International Neuropsychiatric Interview (MINI) questionnaire. Scores of the Aging Males Symptom (AMS) scale were compared between the MDD and non-MDD groups with and without low testosterone values. Forty-two percent of all patients were categorized into the MDD group. Only 4% of the patients were considered to be LOH. The MDD group had significantly higher scores on the AMS scale than the LOH and non-MDD with normal testosterone groups. In conclusion, significant numbers of undiagnosed MDD patients visited the LOH clinic. Screening for MDD is an essential step in the LOH outpatient clinic.
目的是明确前来我们迟发性性腺功能减退(LOH)门诊的自荐患者中重度抑郁症(MDD)的发生率,以及在LOH门诊筛查MDD的重要性。对连续200名前来我们LOH门诊的自荐患者进行了评估。使用迷你国际神经精神访谈(MINI)问卷诊断MDD。比较了MDD组与非MDD组(无论睾酮值是否偏低)的老年男性症状(AMS)量表得分。所有患者中有42%被归入MDD组。仅4%的患者被认为患有LOH。MDD组在AMS量表上的得分显著高于LOH组以及睾酮水平正常的非MDD组。总之,大量未被诊断的MDD患者前来LOH门诊就诊。在LOH门诊进行MDD筛查是至关重要的一步。